P08581 MET_HUMAN
Gene name: MET
Protein name: Hepatocyte growth factor receptor
List of molecules and drugs that target protein P08581
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P08581_DB01268 | DB01268 | Sunitinib | inhibitor | IC50(nM) = 5000.0 Kd(nM) = 1200.0 | WINHZLLDWRZWRT-ATVHPVEESA-N | CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C |
2 | P08581_DB02152 | DB02152 | K-252a | n/a | KOZFSFOOLUUIGY-SOLYNIJKSA-N | [H][C@]12C[C@](O)(C(=O)OC)[C@](C)(O1)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13 | |
3 | P08581_DB06314 | DB06314 | SGX-523 | n/a | BCZUAADEACICHN-UHFFFAOYSA-N | CN1C=C(C=N1)C1=NN2C(SC3=CC=C4N=CC=CC4=C3)=NN=C2C=C1 | |
4 | P08581_DB06896 | DB06896 | 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide | n/a | IC50(nM) = 1.8 | OBSFXHDOLBYWRJ-UHFFFAOYSA-N | FC1=CC=C(C=C1)N1C=CC=C(C(=O)NC2=CC=C(OC3=CC=NC4=C3C=CN4)C(F)=C2)C1=O |
5 | P08581_DB06995 | DB06995 | N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide | n/a | IC50(nM) = 35.0 | USBSTVPJNQLYEM-UHFFFAOYSA-N | NC1=NC=CC(OC2=C(F)C=C(NC(=O)NC(=O)CC3=CC=C(F)C=C3)C=C2)=C1 |
6 | P08581_DB06997 | DB06997 | 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide | n/a | IC50(nM) = 110.0 | BMPOCDJEXAXXEZ-UHFFFAOYSA-N | FC1=CC=C(CC(=O)NC(=O)NC2=CC(F)=C(OC3=CC=NC4=C3C=CN4)C=C2)C=C1 |
7 | P08581_DB07369 | DB07369 | N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide | n/a | YMJLSOJLEXWATP-UHFFFAOYSA-N | CN(C1=CC(Cl)=CC=C1)S(=O)(=O)C1=CC2=C(CC3=C(C)C(C)=C(C)N3)C(=O)N=C2C=C1 | |
8 | P08581_DB07969 | DB07969 | 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol | n/a | IC50(nM) = 900.0 | QNCYYRHIUFGGJX-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=C(C=C(C=C2N=C1)C(F)(F)F)C1=CC(O)=CC=C1 |
9 | P08581_DB08079 | DB08079 | AMG-208 | inhibitor | IC50(nM) = 9.0 | HEAIZQNMNCHNFD-UHFFFAOYSA-N | COC1=CC2=NC=CC(OCC3=NN=C4C=CC(=NN34)C3=CC=CC=C3)=C2C=C1 |
10 | P08581_DB08791 | DB08791 | 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE | n/a | IC50(nM) = 82.0 | USLOIFPDNUDIEG-UHFFFAOYSA-N | NC(=O)C1=CN=C2C=CN(C2=C1)S(=O)(=O)C1=CC=CC=C1[N+]([O-])=O |
11 | P08581_DB08865 | DB08865 | Crizotinib | inhibitor | KTEIFNKAUNYNJU-GFCCVEGCSA-N | C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl | |
12 | P08581_DB08875 | DB08875 | Cabozantinib | antagonist | ONIQOQHATWINJY-UHFFFAOYSA-N | COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2 | |
13 | P08581_DB11791 | DB11791 | Capmatinib | inhibitor | LIOLIMKSCNQPLV-UHFFFAOYSA-N | CNC(=O)C1=C(F)C=C(C=C1)C1=NN2C(CC3=CC4=C(C=C3)N=CC=C4)=CN=C2N=C1 | |
14 | P08581_DB11800 | DB11800 | Tivozanib | inhibitor | SPMVMDHWKHCIDT-UHFFFAOYSA-N | COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1 | |
15 | P08581_DB12010 | DB12010 | Fostamatinib | inhibitor | GKDRMWXFWHEQQT-UHFFFAOYSA-N | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC | |
16 | P08581_DB12200 | DB12200 | Tivantinib | n/a | UCEQXRCJXIVODC-PMACEKPBSA-N | O=C1NC(=O)[C@H]([C@@H]1C1=CNC2=CC=CC=C12)C1=CN2CCCC3=C2C1=CC=C3 | |
17 | P08581_DB12267 | DB12267 | Brigatinib | inhibitor | AILRADAXUVEEIR-UHFFFAOYSA-N | COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1 | |
18 | P08581_DB12742 | DB12742 | Amuvatinib | n/a | FOFDIMHVKGYHRU-UHFFFAOYSA-N | S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1 | |
19 | P08581_DB15133 | DB15133 | Tepotinib | inhibitor | AHYMHWXQRWRBKT-UHFFFAOYSA-N | CN1CCC(COC2=CN=C(N=C2)C2=CC(CN3N=C(C=CC3=O)C3=CC(=CC=C3)C#N)=CC=C2)CC1 |